Xenon’s Azetukalner Confirms Phase III Efficacy Signal, Sets Up Mid-Year NDA Filing

 
• By David Wild
  
A representational image of a brain.
Epilepsy is a chronic brain disorder causing recurrent seizures. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Conference Coverage